Sirolimus-induced bronchiolitis obliterans organizing pneumonia in a kidney transplant recipient; a case report and review of literature.

Einollahi, Behzad; Aslani, Jafar; Taghipour, Mehrdad; Motalebi, Mohsen; Karimi-Sari, Hamidreza.

Afiliação

Einollahi B; Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Aslani J; Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Taghipour M; Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Motalebi M; Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Karimi-Sari H; Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

J Nephropathol ; 3(3): 109-13, 2014 Jul.

Article em En | MEDLINE | ID: mdl-25093159

ABSTRACT

BACKGROUND:

Sirolimus is immunosuppressive drug used to prevent rejection in kidney transplantation. Pulmonary problems are one of the serious complications which may be seen after administration of this drug and it is believed that it could be life threatening. CASE PRESENTATION Here in this paper we presented a 49-years-old man with bronchiolitis obliterans organizing pneumonia (BOOP) induced by chronic use of Sirolimus. The disease was diagnosed and successfully treated.